Monitor the special meeting of shareholders to approve the merger, regulatory clearance, and any competing bids. The $3.16/share cash offer provides a floor, but deal risks include shareholder vote and antitrust review. CVR milestones depend on future net sales performance.
Price Chart
Executive Summary
Esperion Therapeutics entered into a definitive agreement to be acquired by ARCHIMED for $3.16 per share in cash, plus contingent milestone payments of up to $100 million tied to future net sales performance. The transaction is expected to close in the third quarter of 2026, subject to shareholder and regulatory approvals.
Key Facts
- Acquisition price of $3.16 per share in cash
- Contingent milestone payments of up to $100 million in aggregate
- Expected closing in Q3 2026
- Agreement and Plan of Merger dated May 1, 2026
- Acquirer is ARCHIMED, a healthcare-focused investment firm
Financial Impact
Acquisition values equity at approximately $515M based on current market cap; plus up to $100M in contingent value rights
Risk Factors
- Shareholder may vote against the merger
- Regulatory approvals may not be obtained
- Contingent milestone payments may not materialize
- Potential competing bids or go-shop period (if any)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-054100 |
| Document: 0001104659-26-054100-index-headers.html | 0001104659-26-054100 |
| Document: 0001104659-26-054100-index.html | 0001104659-26-054100 |
| Document: 0001104659-26-054100.txt | 0001104659-26-054100 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Court Ruling | — | awaiting T+5 | — | — |
Aug 13, 2026 7w ago | Institutional Cluster | — | awaiting T+5 | — | — |
Jul 23, 2026 10w ago | 15-12G | — | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 25-NSE | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 8-K | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jun 16, 2026 15w ago | DEFA14A | $3.17 $3.15 | ▼ −0.63% | ▲ +0.41% | — |
Jun 11, 2026 16w ago | Institutional Cluster | $3.15 $3.17 | ▲ +0.63% | ▲ +0.20% | — |
Jun 9, 2026 16w ago | 8-K | $3.14 $3.16 | ▲ +0.64% | ▼ −2.80% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access